We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy

By LabMedica International staff writers
Posted on 16 Apr 2024

Artificial intelligence (AI) algorithms are increasingly being utilized in various clinical settings, such as dermatology. More...

These algorithms are developed by training a computer with hundreds of thousands or millions of images of various skin conditions, each labeled with details like the diagnosis and patient outcomes. Through a process known as deep learning, the computer learns to identify patterns in the images that are indicative of specific skin diseases, including cancers. Once sufficiently trained, the algorithm can suggest potential diagnoses based on new images of a patient’s skin. However, these algorithms do not operate in isolation; they are used under the supervision of clinicians who evaluate the patient, make their own diagnostic assessments, and decide whether to follow the algorithm's recommendations.

Now, a new study led by researchers at Stanford Medicine (Stanford, CA, USA) has found that AI algorithms, which utilize deep learning, can enhance the accuracy of diagnosing skin cancers. This benefit extends to dermatologists, though the improvement is more pronounced for non-dermatologists. The study analyzed 12 research papers that documented over 67,000 evaluations of possible skin cancers by various medical practitioners, both with and without AI assistance. Findings indicated that healthcare practitioners without AI support accurately diagnosed approximately 75% of actual skin cancer cases and correctly identified about 81.5% of non-cancerous conditions that resembled cancer. The performance of healthcare practitioners improved when they used AI to assist with diagnoses. Their sensitivity increased to about 81.1% and their specificity to 86.1%.

Although these improvements might appear modest, they are crucial for correctly diagnosing patients who are either mistakenly told they do not have cancer when they do, or incorrectly informed they have cancer when they do not. The analysis further revealed that medical students, nurse practitioners, and primary care physicians gained the most from AI assistance, with average improvements of approximately 13 points in sensitivity and 11 points in specificity. While dermatologists and dermatology residents already showed higher overall accuracy, their diagnostic performance also saw gains in sensitivity and specificity with AI assistance. The researchers are now looking to further explore the potential and challenges of integrating AI tools into healthcare, particularly focusing on how physicians' and patients' perceptions and attitudes towards AI could affect its adoption.

“Previous studies have focused on how AI performs when compared with physicians,” said postdoctoral scholar Jiyeong Kim, PhD. “Our study compared physicians working without AI assistance with physicians using AI when diagnosing skin cancers.”

Related Links:
Stanford Medicine


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.